Tag: "pancreatic cancer"
Don’t Use Victoza To Prevent Diabetes
Between normal blood sugar readings and those that will get you a diagnosis of type 2 diabetes, there is something of a grey area. It is called prediabetes – and, as I pointed out here, it’s one of those conditions that has primarily been invented to sell more diabetes drugs. In a new, placebo-controlled study, […]
Trulicity: A Drug All Diabetics Should Dread
Let’s face it, with the rise of the diabetes epidemic Big Pharma is turning out new diabetes drugs like there is no tomorrow. One of these new drugs is Trulicity — a once-a-week injection — that has been fast-tracked onto both the American and European markets, despite serious concerns over its safety. Spot the black […]
Why Trulicity Could Be A Truly Dreadful Diabetes Drug
This is certainly turning out to be a bumper year for new diabetes drugs, which seem to be getting approved at an unprecedented rate. The latest one is called Trulicity, a once-a-week injection from Eli Lilly and Co, which has been fast-tracked onto both the American and European markets, despite serious concerns over its safety. […]
The Link Between Diabetes And Cancer
Diabetes isn’t just about blood sugar control. It is like a warning light flashing on a control panel, telling you that something has gone wrong in the body’s infinitely complex machinery. Over the years, researchers have discovered that there is a link between diabetes and cancer. The nature of this relationship is far from simple […]
Diabetes: Medications That Work Against
Back in the 1960s, it seemed like anything was possible. The rapid advances in science that gave us heart transplants and men on the moon also promised us a disease-free future and ‘a pill for every ill’. That optimistic vision has turned out to be a mirage, because modern medicine has overlooked one basic fact. […]
New Diabetes Drugs Could Cause Pancreatitis
In the past I have highlighted some of the numerous side effects associated with prescription diabetes drugs. This is especially relevant when it comes to new diabetes drugs. A case in point is a new class of diabetes drugs, called GLP-1 agonists, which has already been linked to the increased risks of pancreatitis and pancreatic […]
Recent Comments